Cargando…
Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027927/ https://www.ncbi.nlm.nih.gov/pubmed/31853942 http://dx.doi.org/10.1111/bjh.16320 |
| _version_ | 1783498934606364672 |
|---|---|
| author | Nilsson, Malin S. Hallner, Alexander Brune, Mats Nilsson, Staffan Thorén, Fredrik B. Martner, Anna Hellstrand, Kristoffer |
| author_facet | Nilsson, Malin S. Hallner, Alexander Brune, Mats Nilsson, Staffan Thorén, Fredrik B. Martner, Anna Hellstrand, Kristoffer |
| author_sort | Nilsson, Malin S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7027927 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70279272020-02-24 Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia Nilsson, Malin S. Hallner, Alexander Brune, Mats Nilsson, Staffan Thorén, Fredrik B. Martner, Anna Hellstrand, Kristoffer Br J Haematol Correspondence John Wiley and Sons Inc. 2019-12-18 2020-02 /pmc/articles/PMC7027927/ /pubmed/31853942 http://dx.doi.org/10.1111/bjh.16320 Text en © 2019 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Correspondence Nilsson, Malin S. Hallner, Alexander Brune, Mats Nilsson, Staffan Thorén, Fredrik B. Martner, Anna Hellstrand, Kristoffer Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia |
| title | Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia |
| title_full | Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia |
| title_fullStr | Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia |
| title_full_unstemmed | Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia |
| title_short | Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia |
| title_sort | complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse‐preventive immunotherapy in acute myeloid leukaemia |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7027927/ https://www.ncbi.nlm.nih.gov/pubmed/31853942 http://dx.doi.org/10.1111/bjh.16320 |
| work_keys_str_mv | AT nilssonmalins completeremissionafterthefirstcycleofinductionchemotherapydeterminestheclinicalefficacyofrelapsepreventiveimmunotherapyinacutemyeloidleukaemia AT hallneralexander completeremissionafterthefirstcycleofinductionchemotherapydeterminestheclinicalefficacyofrelapsepreventiveimmunotherapyinacutemyeloidleukaemia AT brunemats completeremissionafterthefirstcycleofinductionchemotherapydeterminestheclinicalefficacyofrelapsepreventiveimmunotherapyinacutemyeloidleukaemia AT nilssonstaffan completeremissionafterthefirstcycleofinductionchemotherapydeterminestheclinicalefficacyofrelapsepreventiveimmunotherapyinacutemyeloidleukaemia AT thorenfredrikb completeremissionafterthefirstcycleofinductionchemotherapydeterminestheclinicalefficacyofrelapsepreventiveimmunotherapyinacutemyeloidleukaemia AT martneranna completeremissionafterthefirstcycleofinductionchemotherapydeterminestheclinicalefficacyofrelapsepreventiveimmunotherapyinacutemyeloidleukaemia AT hellstrandkristoffer completeremissionafterthefirstcycleofinductionchemotherapydeterminestheclinicalefficacyofrelapsepreventiveimmunotherapyinacutemyeloidleukaemia |